Screener
Lifecore Biomedical, Inc. LFCR Adjustment to the redemption value
Adjustment to the redemption value at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment.
The source filing: Lifecore Biomedical, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q3 2026
- Accession
- 0001005286-26-000033
| (in thousands, except share and per share amounts) | Three months ended / June 30,2026 | Three months ended / May 25,2025 | Six months ended / June 30,2026 | Six months ended / May 25,2025 |
|---|---|---|---|---|
| Loss before income taxes | (6,133) | (1,114) | (21,070) | (15,891) |
| Income tax expense | (23) | (33) | (66) | (25) |
| Net loss | (6,156) | (1,147) | (21,136) | (15,916) |
| Preferred stock dividends | (924) | (852) | (1,831) | (1,689) |
| Accretion of preferred stock to redemption value | (47) | (48) | (94) | (96) |
| Loss available to common stockholders | $(7,127) | $(2,047) | $(23,061) | $(17,701) |
| Loss per share, basic and diluted | $(0.19) | $(0.06) | $(0.61) | $(0.48) |
| Weighted average shares outstanding, basic and diluted | 37,574,538 | 37,007,838 | 37,526,230 | 37,014,204 |
Item 1. Financial
FAQ
- What is Lifecore Biomedical, Inc.'s adjustment to the redemption value?
- Lifecore Biomedical, Inc. (LFCR) reported adjustment to the redemption value of $47K in Q2 2026.
- What does adjustment to the redemption value mean?
- Adjustment to the redemption value as reported by Lifecore Biomedical, Inc. Common Stock.
Ask your AI about Lifecore Biomedical, Inc.'s adjustment to the redemption value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude